Civic Intelligence

Carson Sarcoma Foundation

990EZ • Fiscal year 2020 • EIN 46-4728821

Jan 01, 2020 to Dec 31, 2020 • Filed on Apr 15, 2021

PO Box 2212Asheville, NC 28802

(412) 996-6643

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

Score unavailable

No value available

Liabilities-to-assets requires both liabilities and assets on this filing.

Source year 2020

Liabilities / Revenue

Score unavailable

No value available

Liabilities-to-revenue requires both liabilities and revenue on this filing.

Source year 2020

Net Margin

70th percentile

20%

Higher net margin than 70% of similar nonprofits.

2020 filings • 501(c)3 • <$500k nonprofits • Source year 2020

Top Officer Pay

76th percentile

$0

Higher top officer pay than 76% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

2020 filings • 501(c)3 • <$500k nonprofits • Source year 2020

Asset Growth

83rd percentile

63%

Faster asset growth than 83% of similar nonprofits.

2020 filings • 501(c)3 • <$500k nonprofits • Annualized from 2019 to 2020

Revenue Growth

97th percentile

206%

Faster revenue growth than 97% of similar nonprofits.

2020 filings • 501(c)3 • <$500k nonprofits • Annualized from 2019 to 2020

Assets

Up

$164,990

Up $63,979 (+63%) from 2019

Net Assets

Up

$164,990

Up $63,979 (+63%) from 2019

Liabilities

-

No earlier filing loaded for comparison.

Revenue

Up

$127,068

Up $85,560 (+206%) from 2019

Expenses

Up

$101,304

Up $28,995 (+40%) from 2019

Net Income

Up

$25,764

Up $56,565 (+184%) from 2019

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$300K$200K$100K$0Assets 2015: $88,789Net Assets 2015: $88,7892015Assets 2016: $100,551Liabilities 2016: $0Net Assets 2016: $100,5512016Assets 2017: $47,822Net Assets 2017: $47,8222017Assets 2018: $131,812Net Assets 2018: $131,8122018Assets 2019: $101,011Net Assets 2019: $101,0112019Assets 2020: $164,990Net Assets 2020: $164,9902020Assets 2021: $256,564Liabilities 2021: $0Net Assets 2021: $256,5642021Assets 2022: $225,871Net Assets 2022: $225,8712022Assets 2023: $0Net Assets 2023: $02023

Highlighted filing

2020

Assets$164,990
Liabilities-
Net Assets$164,990

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$400K$200K$0-$200K-$400KRevenue 2015: $129,461Expenses 2015: $40,672Net Income 2015: $88,7892015Revenue 2016: $363,845Expenses 2016: $352,083Net Income 2016: $11,7622016Revenue 2017: $39,743Expenses 2017: $92,472Net Income 2017: -$52,7292017Revenue 2018: $127,558Expenses 2018: $43,568Net Income 2018: $83,9902018Revenue 2019: $41,508Expenses 2019: $72,309Net Income 2019: -$30,8012019Revenue 2020: $127,068Expenses 2020: $101,304Net Income 2020: $25,7642020Revenue 2021: $283,758Expenses 2021: $192,184Net Income 2021: $91,5742021Revenue 2022: $21,150Expenses 2022: $51,843Net Income 2022: -$30,6932022Revenue 2023: $23,581Expenses 2023: $249,452Net Income 2023: -$225,8712023

Highlighted filing

2020

Revenue$127,068
Expenses$101,304
Net Income$25,764
Jump To
Filing Snapshot
Filing Period
Jan 1, 2020 to Dec 31, 2020
Signed
Apr 15, 2021
Return Version
2020v4.0
Gross Receipts
$127,068
Mission and Program Overview

Mission

Csf raises funds through families/friends touched by ewing's sarcoma. Efforts will expand to include raising funds from private individuals, corporations, and online activities. Csf partners with a wide array of individuals & institutions to complete csf's mission. These could include, but are not limited to, cancer hospitals, cancer research institutions, other cancer foundations, scientists, biologists, oncologists and pathologists. Csf focuses on targeted cancer research. Targeted cancer research seeks to attack cancer cells while leaving normal cells unharmed. Examples of targeted cancer research include immunotherapy & molecular therapy. Csf seeks out promising therapies that can be utilized by patients within 12-24 months. Csf seeks out projects whose goal is to move their research to stage 1 clinical trials within 24 months.

Program Services

DescriptionGrantsExpenses
THE MISSION OF THE CARSON SARCOMA FOUNDATION IS TO FUND TARGETED CANCER RESEARCH FOCUSED ON INCREASING SURVIVAL FOR THOSE STRICKEN WITH ORPHAN SARCOMA CANCERS ULTIMATELY LEADING TO A CURE. THE INITIAL FOCUS IS ON EWING'S SARCOMA CANCER.$100,000$100,000
Compensation and Service Providers

Employees

NameTitleFull / Part TimeBaseOtherTotal
CHRISTOPHER C CARSONCo-Director-$0--
RANDY W CARSONCo-Director-$0--
DR G THOMAS BUDDBoard Member-$0--
ROBERT NOYES-SMITHBoard Member-$0--
Filing and Contact Details

Filer

Filer Name
Carson Sarcoma Foundation
EIN
46-4728821
Phone
4129966643
Address
PO BOX 2212, ASHEVILLE, NC 28802

Signing Officer

Name
Randy W Carson
Title
Co-director
Phone
4129966643
Signed
2021-04-15
Discuss with paid preparer
Yes

Preparer

Firm
Austin CPA Pc
Address
301 W HAYWOOD ST, ASHEVILLE, NC 28801-3104
Preparer
Joel Chambers
Phone
8287851556
Supplemental Narrative

Additional Explanations

Form 990-ez, Part I, Line 10

Name: cleveland clinic cancer research address: 9500 euclid ave cleveland, oh 44195 cash contribution: 100,000

Form 990-ez, Part I, Line 16

Expenses merchant fees 140 bank fees 114 total 254

Form 990-ez, Part I, Line 20

Paypal account 38,215 paypal balance inadvertently omitted on prior year return included as adjustment to 2020 return.

Form 990-ez, Part III

Csf raises funds through families/friends touched by ewing's sarcoma. Efforts will expand to include raising funds from private individuals, corporations, and online activities. Csf partners with a wide array of individuals & institutions to complete csf's mission. These could include, but are not limited to, cancer hospitals, cancer research institutions, other cancer foundations, scientists, biologists, oncologists and pathologists. Csf focuses on targeted cancer research. Targeted cancer research seeks to attack cancer cells while leaving normal cells unharmed. Examples of targeted cancer research include immunotherapy & molecular therapy. Csf seeks out promising therapies that can be utilized by patients within 12-24 months. Csf seeks out projects whose goal is to move their research to stage 1 clinical trials within 24 months.

Form 990-ez, Part III, Line 28

The mission of the carson sarcoma foundation is to fund targeted cancer research focused on increasing survival for those stricken with orphan sarcoma cancers ultimately leading to a cure. The initial focus is on ewing's sarcoma cancer.

Raw XML Appendix143 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
CompensationExplanation/CompensationExplanationGrp/PersonNm0CHRISTOPHER C CARSON
CompensationExplanation/CompensationExplanationGrp/PersonNm1RANDY W CARSON
CompensationExplanation/CompensationExplanationGrp/PersonNm2DR G THOMAS BUDD
CompensationExplanation/CompensationExplanationGrp/PersonNm3ROBERT NOYESSMITH
IRS990EZ/ActivitiesNotPreviouslyRptInd0false
IRS990EZ/BooksInCareOfDetail/PersonNm0CHRISTOPHER C CARSON
IRS990EZ/BooksInCareOfDetail/PhoneNum04129966643
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt0PO BOX 2212
IRS990EZ/BooksInCareOfDetail/USAddress/CityNm0ASHEVILLE
IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd0NC
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd028802
IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt0101011
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt0164990
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd0false
IRS990EZ/ContributionsGiftsGrantsEtcAmt0127068
IRS990EZ/DonorAdvisedFndsInd0false
IRS990EZ/EngagedInExcessBenefitTransInd0false
IRS990EZ/ExcessOrDeficitForYearAmt025764
IRS990EZ/FeesAndOtherPymtToIndCntrctAmt01050
IRS990EZ/FiledScheduleAInd0true
IRS990EZ/ForeignFinancialAccountInd0false
IRS990EZ/ForeignOfficeInd0false
IRS990EZ/Form1120PolFiledInd0false
IRS990EZ/Form990TotalAssetsGrp/BOYAmt0101011
IRS990EZ/Form990TotalAssetsGrp/EOYAmt0164990
IRS990EZ/GrantsAndSimilarAmountsPaidAmt0100000
IRS990EZ/GrossReceiptsAmt0127068
IRS990EZ/InfoInScheduleOPartIIIInd0X
IRS990EZ/InfoInScheduleOPartIInd0X
IRS990EZ/LobbyingActivitiesInd0false
IRS990EZ/MadeLoansToFromOfficersInd0false
IRS990EZ/MethodOfAccountingCashInd0X
IRS990EZ/NetAssetsOrFundBalancesBOYAmt0101011
IRS990EZ/NetAssetsOrFundBalancesEOYAmt0164990
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt0101011
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt0164990
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt04.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt14.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt2000.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt3000.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0CHRISTOPHER C CARSON
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1RANDY W CARSON
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm2DR G THOMAS BUDD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm3ROBERT NOYES-SMITH
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0CO-DIRECTOR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1CO-DIRECTOR
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt2BOARD MEMBER
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt3BOARD MEMBER
IRS990EZ/OperateHospitalInd0false
IRS990EZ/Organization501c3Ind0X
IRS990EZ/OrganizationDissolvedEtcInd0false
IRS990EZ/OrganizationHadUBIInd0false
IRS990EZ/OtherChangesInNetAssetsAmt038215
IRS990EZ/OtherExpensesTotalAmt0254
IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt0NONE
IRS990EZ/PartVIOfCompOfHghstPdEmplTxt0NONE
IRS990EZ/PoliticalCampaignActyInd0false
IRS990EZ/PrimaryExemptPurposeTxt0CSF RAISES FUNDS THROUGH FAMILIES/FRIENDS TOUCHED BY EWING'S SARCOMA. EFFORTS WILL EXPAND TO INCLUDE RAISING FUNDS FROM PRIVATE INDIVIDUALS, CORPORATIONS, AND ONLINE ACTIVITIES. CSF PARTNERS WITH A WIDE ARRAY OF INDIVIDUALS & INSTITUTIONS TO COMPLETE CSF'S MISSION. THESE COULD INCLUDE, BUT ARE NOT LIMITED TO, CANCER HOSPITALS, CANCER RESEARCH INSTITUTIONS, OTHER CANCER FOUNDATIONS, SCIENTISTS, BIOLOGISTS, ONCOLOGISTS AND PATHOLOGISTS. CSF FOCUSES ON TARGETED CANCER RESEARCH. TARGETED CANCER RESEARCH SEEKS TO ATTACK CANCER CELLS WHILE LEAVING NORMAL CELLS UNHARMED. EXAMPLES OF TARGETED CANCER RESEARCH INCLUDE IMMUNOTHERAPY & MOLECULAR THERAPY. CSF SEEKS OUT PROMISING THERAPIES THAT CAN BE UTILIZED BY PATIENTS WITHIN 12-24 MONTHS. CSF SEEKS OUT PROJECTS WHOSE GOAL IS TO MOVE THEIR RESEARCH TO STAGE 1 CLINICAL TRIALS WITHIN 24 MONTHS.
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt0THE MISSION OF THE CARSON SARCOMA FOUNDATION IS TO FUND TARGETED CANCER RESEARCH FOCUSED ON INCREASING SURVIVAL FOR THOSE STRICKEN WITH ORPHAN SARCOMA CANCERS ULTIMATELY LEADING TO A CURE. THE INITIAL FOCUS IS ON EWING'S SARCOMA CANCER.
IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt0100000
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt0100000
IRS990EZ/ProhibitedTaxShelterTransInd0false
IRS990EZ/RelatedOrganizationCtrlEntInd0false
IRS990EZ/ScheduleBNotRequiredInd0X
IRS990EZ/SchoolOperatingInd0false
IRS990EZ/SubjectToProxyTaxInd0false
IRS990EZ/TanningServicesProvidedInd0false
IRS990EZ/TotalExpensesAmt0101304
IRS990EZ/TotalProgramServiceExpensesAmt0100000
IRS990EZ/TotalRevenueAmt0127068
IRS990EZ/TransactionWithControlEntInd0false
IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990EZ/TypeOfOrganizationCorpInd0X
IRS990EZ/WebsiteAddressTxt0HTTP://WWW.CARSONSARCOMAFOUNDATION.ORG
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearAmt0127068
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus1YearAmt038061
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus2YearsAmt0127558
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus3YearsAmt039743
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus4YearsAmt0363845
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/TotalAmt0696275
IRS990ScheduleA/InvestmentIncomeCYPct00.00000
IRS990ScheduleA/InvestmentIncomePYPct00.00000
IRS990ScheduleA/PubliclySupportedOrg509a2Ind0X
IRS990ScheduleA/PublicSupportCY509Pct01.00000
IRS990ScheduleA/PublicSupportPY509Pct01.00000
IRS990ScheduleA/PublicSupportTotal509Amt0696275
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY509Ind0X
IRS990ScheduleA/Total509Grp/CurrentTaxYearAmt0127068
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus1YearAmt038061
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus2YearsAmt0127558
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus3YearsAmt039743
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus4YearsAmt0363845
IRS990ScheduleA/Total509Grp/TotalAmt0696275
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearAmt0127068
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus1YearAmt038061
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus2YearsAmt0127558
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus3YearsAmt039743
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus4YearsAmt0363845
IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt0696275
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0NAME: CLEVELAND CLINIC CANCER RESEARCH ADDRESS: 9500 EUCLID AVE CLEVELAND, OH 44195 CASH CONTRIBUTION: 100,000
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1EXPENSES MERCHANT FEES 140 BANK FEES 114 TOTAL 254
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2PAYPAL ACCOUNT 38,215 PAYPAL BALANCE INADVERTENTLY OMITTED ON PRIOR YEAR RETURN INCLUDED AS ADJUSTMENT TO 2020 RETURN.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3CSF RAISES FUNDS THROUGH FAMILIES/FRIENDS TOUCHED BY EWING'S SARCOMA. EFFORTS WILL EXPAND TO INCLUDE RAISING FUNDS FROM PRIVATE INDIVIDUALS, CORPORATIONS, AND ONLINE ACTIVITIES. CSF PARTNERS WITH A WIDE ARRAY OF INDIVIDUALS & INSTITUTIONS TO COMPLETE CSF'S MISSION. THESE COULD INCLUDE, BUT ARE NOT LIMITED TO, CANCER HOSPITALS, CANCER RESEARCH INSTITUTIONS, OTHER CANCER FOUNDATIONS, SCIENTISTS, BIOLOGISTS, ONCOLOGISTS AND PATHOLOGISTS. CSF FOCUSES ON TARGETED CANCER RESEARCH. TARGETED CANCER RESEARCH SEEKS TO ATTACK CANCER CELLS WHILE LEAVING NORMAL CELLS UNHARMED. EXAMPLES OF TARGETED CANCER RESEARCH INCLUDE IMMUNOTHERAPY & MOLECULAR THERAPY. CSF SEEKS OUT PROMISING THERAPIES THAT CAN BE UTILIZED BY PATIENTS WITHIN 12-24 MONTHS. CSF SEEKS OUT PROJECTS WHOSE GOAL IS TO MOVE THEIR RESEARCH TO STAGE 1 CLINICAL TRIALS WITHIN 24 MONTHS.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt4THE MISSION OF THE CARSON SARCOMA FOUNDATION IS TO FUND TARGETED CANCER RESEARCH FOCUSED ON INCREASING SURVIVAL FOR THOSE STRICKEN WITH ORPHAN SARCOMA CANCERS ULTIMATELY LEADING TO A CURE. THE INITIAL FOCUS IS ON EWING'S SARCOMA CANCER.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990-EZ, PART I, LINE 10
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990-EZ, PART I, LINE 16
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990-EZ, PART I, LINE 20
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3FORM 990-EZ, PART III
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc4FORM 990-EZ, PART III, LINE 28
ReturnHeader/BuildTS02022-09-23 18:48:47Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd0true
ReturnHeader/BusinessOfficerGrp/PersonNm0RANDY W CARSON
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0CO-DIRECTOR
ReturnHeader/BusinessOfficerGrp/PhoneNum04129966643
ReturnHeader/BusinessOfficerGrp/SignatureDt02021-04-15
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0CARSON SARCOMA FOUNDATION
ReturnHeader/Filer/BusinessNameControlTxt0CARS
ReturnHeader/Filer/EIN0464728821
ReturnHeader/Filer/PhoneNum04129966643
ReturnHeader/Filer/USAddress/AddressLine1Txt0PO BOX 2212
ReturnHeader/Filer/USAddress/CityNm0ASHEVILLE
ReturnHeader/Filer/USAddress/StateAbbreviationCd0NC
ReturnHeader/Filer/USAddress/ZIPCd028802
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0463060158
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0AUSTIN CPA PC
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt0301 W HAYWOOD ST
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0ASHEVILLE
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0NC
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd0288013104
ReturnHeader/PreparerPersonGrp/PhoneNum08287851556
ReturnHeader/PreparerPersonGrp/PreparationDt02021-04-05
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0JOEL CHAMBERS
ReturnHeader/ReturnTs02021-04-12T11:54:51-05:00
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/SigningOfficerGrp/PersonFullName/PersonFirstNm0RANDY
ReturnHeader/SigningOfficerGrp/PersonFullName/PersonLastNm0CARSON
ReturnHeader/TaxPeriodBeginDt02020-01-01
ReturnHeader/TaxPeriodEndDt02020-12-31
ReturnHeader/TaxYr02020

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings